ROLE: Associate Creative Director | Copy
REVLIMID is an oral therapy indicated for the treatment of multiple myeloma—an incurable cancer of the plasma cells in the blood. It's also indicated for several other blood cancers.
I wrote and was responsible for all copy and annotations of the REVLIMID website. To see the full site visit https://www.revlimid.com
